Measuring the gains from medical research :: an economic approach /
Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 bill...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Chicago :
University of Chicago Press,
©2003.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development. The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book. |
| Beschreibung: | 1 online resource (vi, 263 pages) : illustrations |
| Bibliographie: | Includes bibliographical references and indexes. |
| ISBN: | 9780226551791 0226551792 9786612584916 6612584912 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn642206239 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 100617s2003 ilua ob 101 0 eng d | ||
| 010 | |a 2002010963 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d IDEBK |d E7B |d OCLCQ |d OCLCF |d DKDLA |d OCLCO |d OCLCQ |d NLGGC |d EBLCP |d DEBSZ |d OCLCQ |d OCL |d TEFOD |d OCLCQ |d AZK |d STBDS |d COCUF |d TOA |d AGLDB |d MOR |d OCLCO |d PIFAG |d ZCU |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d STF |d VNS |d WRM |d OCLCQ |d VTS |d NRAMU |d ICG |d REC |d VT2 |d OCLCO |d AU@ |d OCLCQ |d OCLCO |d WYU |d OCLCO |d OCLCA |d LEAUB |d DKC |d OCLCQ |d OCLCO |d M8D |d UX1 |d OCLCQ |d OCLCA |d UKCRE |d VLY |d AJS |d OCLCO |d OCL |d OCLCQ |d SFB |d OCLCQ |d OCLCO |d INARC |d OCLCQ |d OCLCL |d OCLCQ | ||
| 019 | |a 635292171 |a 649906149 |a 764539948 |a 871976945 |a 961513492 |a 962590845 |a 988504742 |a 992080433 |a 1037920773 |a 1038605827 |a 1045517408 |a 1055363474 |a 1058770020 |a 1064093176 |a 1081284742 |a 1084418524 |a 1153469053 |a 1162385802 |a 1228541638 | ||
| 020 | |a 9780226551791 |q (electronic bk.) | ||
| 020 | |a 0226551792 |q (electronic bk.) | ||
| 020 | |z 0226551784 |q (cloth ; |q alk. paper) | ||
| 020 | |z 9780226551784 | ||
| 020 | |a 9786612584916 | ||
| 020 | |a 6612584912 | ||
| 035 | |a (OCoLC)642206239 |z (OCoLC)635292171 |z (OCoLC)649906149 |z (OCoLC)764539948 |z (OCoLC)871976945 |z (OCoLC)961513492 |z (OCoLC)962590845 |z (OCoLC)988504742 |z (OCoLC)992080433 |z (OCoLC)1037920773 |z (OCoLC)1038605827 |z (OCoLC)1045517408 |z (OCoLC)1055363474 |z (OCoLC)1058770020 |z (OCoLC)1064093176 |z (OCoLC)1081284742 |z (OCoLC)1084418524 |z (OCoLC)1153469053 |z (OCoLC)1162385802 |z (OCoLC)1228541638 | ||
| 037 | |a A0A8BD74-6EB0-4D8F-99E7-6B67ADF3620D |b OverDrive, Inc. |n http://www.overdrive.com | ||
| 050 | 4 | |a R852 |b .M383 2003eb | |
| 060 | 4 | |a 2003 G-890 | |
| 060 | 4 | |a W 20.5 |b M484 2003 | |
| 072 | 7 | |a MED |x 002000 |2 bisacsh | |
| 072 | 7 | |a MED |x 095000 |2 bisacsh | |
| 082 | 7 | |a 362.1/068 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Measuring the gains from medical research : |b an economic approach / |c edited by Kevin M. Murphy and Robert H. Topel. |
| 260 | |a Chicago : |b University of Chicago Press, |c ©2003. | ||
| 300 | |a 1 online resource (vi, 263 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and indexes. | ||
| 505 | 0 | |a The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer. | |
| 588 | 0 | |a Print version record. | |
| 520 | 8 | |a Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development. The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book. | |
| 546 | |a English. | ||
| 650 | 0 | |a Medicine |x Research |x Cost effectiveness |v Congresses. | |
| 650 | 0 | |a Cost effectiveness. |0 http://id.loc.gov/authorities/subjects/sh85033197 | |
| 650 | 1 | 2 | |a Research |x economics |
| 650 | 2 | 2 | |a Cost-Benefit Analysis |
| 650 | 2 | 2 | |a Health Expenditures |x trends |
| 650 | 2 | 2 | |a Health Status |
| 650 | 2 | 2 | |a Research Support as Topic |
| 650 | 2 | 2 | |a Socioeconomic Factors |
| 650 | 6 | |a Médecine |x Recherche |x Coût-efficacité |v Congrès. | |
| 650 | 6 | |a Coût-efficacité. | |
| 650 | 7 | |a cost benefit analysis. |2 aat | |
| 650 | 7 | |a MEDICAL |x Administration. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Practice Management & Reimbursement. |2 bisacsh | |
| 650 | 7 | |a Cost effectiveness |2 fast | |
| 650 | 7 | |a Medicine |x Research |x Cost effectiveness |2 fast | |
| 650 | 1 | 7 | |a Onderzoek. |2 gtt |
| 650 | 1 | 7 | |a Geneeskunde. |2 gtt |
| 650 | 1 | 7 | |a Geneesmiddelen. |2 gtt |
| 650 | 1 | 7 | |a Kosten-batenanalyse. |2 gtt |
| 655 | 0 | |a Electronic books. | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Murphy, Kevin M. | |
| 700 | 1 | |a Topel, Robert H. | |
| 758 | |i has work: |a Measuring the gains from medical research (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFywprq8wXymgKK87Rqk9P |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Measuring the gains from medical research. |d Chicago : University of Chicago Press, ©2003 |z 9780226551784 |w (DLC) 2002010963 |w (OCoLC)50199085 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=322681 |3 Volltext |
| 938 | |a Internet Archive |b INAR |n measuringgainsfr0000unse | ||
| 938 | |a ebrary |b EBRY |n ebr10389542 | ||
| 938 | |a EBSCOhost |b EBSC |n 322681 | ||
| 938 | |a Oxford University Press USA |b OUPR |n EDZ0000115688 | ||
| 938 | |a YBP Library Services |b YANK |n 3314849 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL534569 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn642206239 |
|---|---|
| _version_ | 1816881722528104448 |
| adam_text | |
| any_adam_object | |
| author2 | Murphy, Kevin M. Topel, Robert H. |
| author2_role | |
| author2_variant | k m m km kmm r h t rh rht |
| author_facet | Murphy, Kevin M. Topel, Robert H. |
| author_sort | Murphy, Kevin M. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | R852 |
| callnumber-raw | R852 .M383 2003eb |
| callnumber-search | R852 .M383 2003eb |
| callnumber-sort | R 3852 M383 42003EB |
| callnumber-subject | R - General Medicine |
| collection | ZDB-4-EBA |
| contents | The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer. |
| ctrlnum | (OCoLC)642206239 |
| dewey-full | 362.1/068 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1/068 |
| dewey-search | 362.1/068 |
| dewey-sort | 3362.1 268 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06649cam a2200889 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn642206239</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">100617s2003 ilua ob 101 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2002010963</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">DKDLA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">TEFOD</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">STBDS</subfield><subfield code="d">COCUF</subfield><subfield code="d">TOA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">MOR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">ICG</subfield><subfield code="d">REC</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LEAUB</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">UX1</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">VLY</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">635292171</subfield><subfield code="a">649906149</subfield><subfield code="a">764539948</subfield><subfield code="a">871976945</subfield><subfield code="a">961513492</subfield><subfield code="a">962590845</subfield><subfield code="a">988504742</subfield><subfield code="a">992080433</subfield><subfield code="a">1037920773</subfield><subfield code="a">1038605827</subfield><subfield code="a">1045517408</subfield><subfield code="a">1055363474</subfield><subfield code="a">1058770020</subfield><subfield code="a">1064093176</subfield><subfield code="a">1081284742</subfield><subfield code="a">1084418524</subfield><subfield code="a">1153469053</subfield><subfield code="a">1162385802</subfield><subfield code="a">1228541638</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780226551791</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0226551792</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0226551784</subfield><subfield code="q">(cloth ;</subfield><subfield code="q">alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780226551784</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786612584916</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6612584912</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)642206239</subfield><subfield code="z">(OCoLC)635292171</subfield><subfield code="z">(OCoLC)649906149</subfield><subfield code="z">(OCoLC)764539948</subfield><subfield code="z">(OCoLC)871976945</subfield><subfield code="z">(OCoLC)961513492</subfield><subfield code="z">(OCoLC)962590845</subfield><subfield code="z">(OCoLC)988504742</subfield><subfield code="z">(OCoLC)992080433</subfield><subfield code="z">(OCoLC)1037920773</subfield><subfield code="z">(OCoLC)1038605827</subfield><subfield code="z">(OCoLC)1045517408</subfield><subfield code="z">(OCoLC)1055363474</subfield><subfield code="z">(OCoLC)1058770020</subfield><subfield code="z">(OCoLC)1064093176</subfield><subfield code="z">(OCoLC)1081284742</subfield><subfield code="z">(OCoLC)1084418524</subfield><subfield code="z">(OCoLC)1153469053</subfield><subfield code="z">(OCoLC)1162385802</subfield><subfield code="z">(OCoLC)1228541638</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">A0A8BD74-6EB0-4D8F-99E7-6B67ADF3620D</subfield><subfield code="b">OverDrive, Inc.</subfield><subfield code="n">http://www.overdrive.com</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R852</subfield><subfield code="b">.M383 2003eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2003 G-890</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">W 20.5</subfield><subfield code="b">M484 2003</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">002000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">095000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.1/068</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Measuring the gains from medical research :</subfield><subfield code="b">an economic approach /</subfield><subfield code="c">edited by Kevin M. Murphy and Robert H. Topel.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Chicago :</subfield><subfield code="b">University of Chicago Press,</subfield><subfield code="c">©2003.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (vi, 263 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1="8" ind2=" "><subfield code="a">Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development. The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="x">Research</subfield><subfield code="x">Cost effectiveness</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cost effectiveness.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85033197</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Research</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Cost-Benefit Analysis</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Expenditures</subfield><subfield code="x">trends</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Health Status</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Research Support as Topic</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Socioeconomic Factors</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine</subfield><subfield code="x">Recherche</subfield><subfield code="x">Coût-efficacité</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Coût-efficacité.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cost benefit analysis.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Administration.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Practice Management & Reimbursement.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cost effectiveness</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="x">Research</subfield><subfield code="x">Cost effectiveness</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Onderzoek.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Geneeskunde.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Geneesmiddelen.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Kosten-batenanalyse.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Murphy, Kevin M.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Topel, Robert H.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Measuring the gains from medical research (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFywprq8wXymgKK87Rqk9P</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Measuring the gains from medical research.</subfield><subfield code="d">Chicago : University of Chicago Press, ©2003</subfield><subfield code="z">9780226551784</subfield><subfield code="w">(DLC) 2002010963</subfield><subfield code="w">(OCoLC)50199085</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=322681</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">measuringgainsfr0000unse</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10389542</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">322681</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Oxford University Press USA</subfield><subfield code="b">OUPR</subfield><subfield code="n">EDZ0000115688</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3314849</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL534569</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic books. Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Electronic books. Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| id | ZDB-4-EBA-ocn642206239 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:14Z |
| institution | BVB |
| isbn | 9780226551791 0226551792 9786612584916 6612584912 |
| language | English |
| lccn | 2002010963 |
| oclc_num | 642206239 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (vi, 263 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | University of Chicago Press, |
| record_format | marc |
| spelling | Measuring the gains from medical research : an economic approach / edited by Kevin M. Murphy and Robert H. Topel. Chicago : University of Chicago Press, ©2003. 1 online resource (vi, 263 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and indexes. The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer. Print version record. Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development. The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book. English. Medicine Research Cost effectiveness Congresses. Cost effectiveness. http://id.loc.gov/authorities/subjects/sh85033197 Research economics Cost-Benefit Analysis Health Expenditures trends Health Status Research Support as Topic Socioeconomic Factors Médecine Recherche Coût-efficacité Congrès. Coût-efficacité. cost benefit analysis. aat MEDICAL Administration. bisacsh MEDICAL Practice Management & Reimbursement. bisacsh Cost effectiveness fast Medicine Research Cost effectiveness fast Onderzoek. gtt Geneeskunde. gtt Geneesmiddelen. gtt Kosten-batenanalyse. gtt Electronic books. Congress proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf Murphy, Kevin M. Topel, Robert H. has work: Measuring the gains from medical research (Text) https://id.oclc.org/worldcat/entity/E39PCFywprq8wXymgKK87Rqk9P https://id.oclc.org/worldcat/ontology/hasWork Print version: Measuring the gains from medical research. Chicago : University of Chicago Press, ©2003 9780226551784 (DLC) 2002010963 (OCoLC)50199085 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=322681 Volltext |
| spellingShingle | Measuring the gains from medical research : an economic approach / The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer. Medicine Research Cost effectiveness Congresses. Cost effectiveness. http://id.loc.gov/authorities/subjects/sh85033197 Research economics Cost-Benefit Analysis Health Expenditures trends Health Status Research Support as Topic Socioeconomic Factors Médecine Recherche Coût-efficacité Congrès. Coût-efficacité. cost benefit analysis. aat MEDICAL Administration. bisacsh MEDICAL Practice Management & Reimbursement. bisacsh Cost effectiveness fast Medicine Research Cost effectiveness fast Onderzoek. gtt Geneeskunde. gtt Geneesmiddelen. gtt Kosten-batenanalyse. gtt |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85033197 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | Measuring the gains from medical research : an economic approach / |
| title_auth | Measuring the gains from medical research : an economic approach / |
| title_exact_search | Measuring the gains from medical research : an economic approach / |
| title_full | Measuring the gains from medical research : an economic approach / edited by Kevin M. Murphy and Robert H. Topel. |
| title_fullStr | Measuring the gains from medical research : an economic approach / edited by Kevin M. Murphy and Robert H. Topel. |
| title_full_unstemmed | Measuring the gains from medical research : an economic approach / edited by Kevin M. Murphy and Robert H. Topel. |
| title_short | Measuring the gains from medical research : |
| title_sort | measuring the gains from medical research an economic approach |
| title_sub | an economic approach / |
| topic | Medicine Research Cost effectiveness Congresses. Cost effectiveness. http://id.loc.gov/authorities/subjects/sh85033197 Research economics Cost-Benefit Analysis Health Expenditures trends Health Status Research Support as Topic Socioeconomic Factors Médecine Recherche Coût-efficacité Congrès. Coût-efficacité. cost benefit analysis. aat MEDICAL Administration. bisacsh MEDICAL Practice Management & Reimbursement. bisacsh Cost effectiveness fast Medicine Research Cost effectiveness fast Onderzoek. gtt Geneeskunde. gtt Geneesmiddelen. gtt Kosten-batenanalyse. gtt |
| topic_facet | Medicine Research Cost effectiveness Congresses. Cost effectiveness. Research economics Cost-Benefit Analysis Health Expenditures trends Health Status Research Support as Topic Socioeconomic Factors Médecine Recherche Coût-efficacité Congrès. Coût-efficacité. cost benefit analysis. MEDICAL Administration. MEDICAL Practice Management & Reimbursement. Cost effectiveness Medicine Research Cost effectiveness Onderzoek. Geneeskunde. Geneesmiddelen. Kosten-batenanalyse. Electronic books. Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=322681 |
| work_keys_str_mv | AT murphykevinm measuringthegainsfrommedicalresearchaneconomicapproach AT topelroberth measuringthegainsfrommedicalresearchaneconomicapproach |